- What OMB’s Proposed Grants Rule Changes
- From Deference to “Advisory”: How Peer Review’s Role Shrinks
- Grant Peer Review: Common Questions Answered
- Expanded Termination Authority and Award-Level Risk
- What This Means for Research Administrators
- What Happens Next
The Office of Management and Budget (OMB) has proposed a rewrite of the federal government’s grant-making rulebook that would change how grant peer review functions across agencies including the National Institutes of Health (NIH), the National Science Foundation (NSF) and the Department of Energy. According to reporting from STAT News, Inside Higher Ed, Science and NPR, the draft rule would convert the long-standing “Uniform Guidance” (2 CFR Part 200) into a binding “Uniform Grants Regulation,” subordinating scientific merit review to a new layer of political sign-off and giving agency political appointees explicit authority to terminate awards that no longer track administration priorities.
For research administrators, the proposal is not a routine compliance update. It touches the mechanism — independent expert review — that has underpinned federal research funding decisions for more than half a century.
What OMB’s Proposed Grants Rule Changes
Uniform Guidance governs financial assistance rules across virtually every federal grant-making agency, covering everything from allowable costs to audit requirements. OMB’s proposal would elevate that guidance to a binding regulation and layer several new mechanisms on top of it. The core changes reported by STAT, Inside Higher Ed, Science and NPR include:
- A mandatory pre-issuance review of discretionary grant awards by senior political appointees before funds are released.
- Reclassification of peer-review recommendations as advisory rather than binding or routinely deferred to.
- An undefined “Gold Standard Science” criterion appointees may apply during sign-off.
- Expanded termination authority for awards deemed misaligned with agency priorities, including multi-year awards already underway.
- New pre-approval requirements for costs tied to publications, conference attendance and journal subscriptions.
- A “domestic-first” preference framework for research and development awards.
- Prohibitions on funding tied to diversity, equity and inclusion (DEI) activities, “gender ideology,” or research supporting disparate-impact liability theories.
- Elimination of fixed-amount subawards.
The public comment period is reported to close on 13 July 2026, with an anticipated effective date of 1 October 2026 if the rule is finalised largely as proposed.
From Deference to “Advisory”: How Peer Review’s Role Shrinks
Under current practice, agencies such as NIH route applications through scientific review groups or study sections, which score proposals on significance, approach, innovation and investigator qualifications. Program officials retain formal award authority, but in practice they defer heavily to review scores and percentile rankings to set paylines.
The proposed rule text, as reported across multiple outlets, states that peer-review recommendations “are not ministerially ratified, routinely deferred to, or otherwise treated as de facto binding” by senior appointees. That is a structural change: a proposal that clears scientific review with a strong score could still be delayed, reprioritised or rejected at a political pre-issuance gate that sits above the merit-review process rather than alongside it.
Research associations — including the Association of Public and Land-grant Universities (APLU), the American Association for Cancer Research (AACR) and the Computing Research Association (CRA) — have raised concerns that the change would insert non-scientific criteria into funding decisions that have historically been insulated from politics precisely to protect scientific rigour and public trust.
| Aspect | Current practice | Proposed rule |
|---|---|---|
| Peer-review status | De facto determinative for most competitive awards | Explicitly advisory |
| Final sign-off | Program/agency officials, largely deferential to review scores | Senior political appointees, mandatory pre-issuance review |
| Termination grounds | Non-compliance, budget, performance | Adds “no longer aligned with agency priorities,” including mid-award |
| Allowable costs | Publications, conferences, subscriptions generally allowable | Pre-approval required for these cost categories |
| Subaward mechanism | Fixed-amount subawards permitted | Fixed-amount subawards eliminated |
Grant Peer Review: Common Questions Answered
What is a peer-reviewed grant?
A peer-reviewed grant is funding awarded after independent subject-matter experts assess a proposal’s scientific merit — its significance, approach, feasibility and investigator qualifications — typically through a scored study section or review panel. At NIH, review groups assign priority scores that traditionally shape funding decisions, though final award authority sits with the agency, not the reviewers.
What is the peer review process for grant applications?
The peer review process for grant applications routes each proposal to subject-matter reviewers, who score it against published criteria and then discuss and rank applications in a panel meeting. Agencies use these rankings to set paylines and prioritise funding. Under OMB’s proposed rule, that ranking becomes one advisory input rather than the determining factor in a funding decision.
Do grant reviewers get paid?
Yes. Federal agencies, including NIH, typically pay peer reviewers a daily honorarium plus travel expenses for study section service. Many reviewers describe the compensation as modest relative to the time required to read, score and discuss a full panel’s worth of competing applications ahead of each review cycle.
Expanded Termination Authority and Award-Level Risk
Beyond the review gate itself, the proposal reported by STAT, Science and Inside Higher Ed would broaden agencies’ authority to suspend or terminate grants — including multi-year awards already in progress — if they are deemed no longer aligned with agency priorities or the “national interest.” It would also widen risk assessment of applicants to consider an institution’s affiliation with organisations engaged in activities that “violate Federal law, undermine public safety or national security, or advocate for the overthrow of the United States Government,” a standard with considerable interpretive latitude.
Paired with new pre-approval requirements for publication, conference and journal-subscription costs, and the removal of fixed-amount subawards, the combined effect is a research-funding environment where mid-project risk is materially higher than under the current framework, even for awards that passed scientific review cleanly.
What This Means for Research Administrators
For institutions managing portfolios that depend on merit-reviewed research funding, the proposal raises operational, not just scientific, questions. Recommended near-term actions include:
- Model termination risk explicitly in multi-year budget and staffing plans, rather than treating a scored, funded award as a settled commitment.
- Audit cost-approval workflows for publication, conference and subscription spending now, ahead of any pre-approval mandate taking effect.
- Brief principal investigators on the distinction between a favourable peer-review score and a final funding decision under the proposed pre-issuance review.
- Coordinate institutional comments through professional associations such as NCURA and ARMA before the docket closes.
- Track subaward structures that rely on fixed-amount mechanisms, which the proposal would eliminate.
Offices that have historically treated peer-review outcomes as the primary predictor of award stability will need a second, policy-alignment layer in their risk assessment — one that is harder to forecast because it depends on political judgement rather than published scoring criteria.
What Happens Next
The proposed rule remains open for public comment, with reporting placing the deadline at 13 July 2026 and a possible effective date of 1 October 2026 if OMB finalises it substantially as drafted. Scientific and higher-education associations are expected to submit extensive comments opposing the advisory reclassification of peer review, and legal challenges are plausible if the rule is finalised without significant revision, given its scope relative to existing statutory peer-review requirements at agencies such as NIH.
Until the final text is published, research administrators should treat every provision summarised here as subject to change — but the direction of travel is unambiguous: less deference to scientific merit review, and more discretionary authority at the award-decision and award-termination stages. Institutions that update their risk models and compliance workflows now will be better placed to respond once the rule, in whatever form it takes, becomes binding.
